Company

WuXi XDC Reports 114.4% YOY Revenue Growth in 2023, Driven by ADC CRDMO Business

CompanyDrug

Jiangsu Hengrui’s Generic Version of Tepadina Approved for Transplantation Conditioning in China

CompanyDrug

MSD’s Phase III Trial of Keytruda Plus Lynparza Misses Primary Endpoints in NSCLC

Company

Sandoz Expands Antibiotics Production with New Austrian Factory

CompanyDrug

Shanghai Institute’s Biosimilar Rituximab Approved by NMPA for Lymphoma Treatments

CompanyDrug

EMA Panel Backs Novartis’s Fabhalta for PNH Treatment, Awaits EC Decision

Company

Sumitomo Pharma’s China CEO Highlights Strategic Importance of Local Market

Company

Roche Invests EUR 90 Million in New Gene Therapy Center in Germany

CompanyDrug

Sanofi Projects EUR 13 Billion in Dupixent Sales for 2024 Despite Q1 Challenges

CompanyDrug

FibroGen’s Roxadustat Approved in Macau for Chronic Kidney Disease-Related Anemia

Policy / Regulatory

China’s Commerce Minister Meets with Global Pharma Leaders to Discuss Innovation Cooperation

CompanyDrug

Yifan Pharmaceutical’s F-627 Approved by European Commission for Marketing in EU